INGATE

From The Sip Trunking Experts

[May 03, 2007]

2007 BIO International Convention Exhibitor Profiles Continued, M through Z

BOSTON --(Business Wire)-- 2007 BIO International Convention, the Global Event for Biotechnology, takes place May 06 - 09, 2007 at the Boston Convention & Exhibition Center. For in-depth information about the event, visit http://www.bio2007.org/Media/releases.html.


Below are profiles from BIO exhibitors, listed M through Z.

Business Wire is the official news wire for 2007 BIO International Convention. Breaking news releases and photos are available at Tradeshownews.com, Business Wire's trade show, conference, and event news resource as well as the official show site.

Company:            Maxiom Group
Booth:             Booth 533/Pod D12
Media Contact:         Jennifer Fiorentino
Phone:             781-239-1030
E-mail:            jfiorentino@parnold.com
Web:              www.maxiomgroup.com
Maxiom Group is a leading strategic business and IT consulting firm
exclusively serving the life sciences industry. Located in Waltham,
Massachusetts, Maxiom Group specializes in transforming emerging,
established, and mature biotechnology, pharmaceutical, and medical
device companies at each stage of their life cycle by solving mission
critical business issues. From drug discovery and development, to
clinical trials, to commercial launch and sustained market
leadership, Maxiom Group clients rely on our unique focus, insight
and approach. For more information please visit www.maxiomgroup.com.
Company:            MEDICEN PARIS REGION
Booth:             1307
Media Contact:         Isabelle Boyer de la Giroday
Phone:             33 1 44 49 30 00
E-mail:            igiroday@medicen.org
Web:              www.medicen.org
Medicen Paris Region unites all the key life science and healthcare
players in the Paris metropolitan area. Located at the heart of
Europe's leading regional economy, the cluster brings together the
highest concentration of healthcare expertise and resources in
Europe.
This ambition is shared by major pharmaceutical and healthcare
companies, biotech & medtech entrepreneurs, public and private
research organizations, Europe's leading hospital network and the
region's universities and Grandes Ecoles.
These stakeholders are developing close partnerships and active
collaborations around innovative projects, company start-ups and
business creation. For additional information email
contact@medicen.org.
Company:            MedMira Laboratories Inc.
Booth:             807 - Atlantic Canada Pavilion
Ticker Symbol & Exchange:   MIR TSX Venture exchange
Media Contact:         Dr. James Smith - VP - Corporate
                Affairs and Human Resources
Phone:             902 450 1588
E-mail:            ir@medmira.com
Web:              www.medmira.com
MedMira's focus is helping people know...(R). We do this by bringing
quality diagnostic solutions closer to end-users - laboratory
professionals, healthcare providers and individuals.
In a world continually faced with overwhelming healthcare epidemics
and challenges, healthcare providers, researchers, governments and
businesses are not standing still and neither is MedMira. We have a
robust line of rapid diagnostics for today's healthcare challenges.
The tools we provide can help control and prevent the HIV and
Hepatitis C epidemics from reaching future generations. Today, HIV
and Hepatitis C are two of the top 10 causes of infectious disease
deaths worldwide.
MedMira is developing revolutionary solutions to prevent tomorrow's
epidemics. As we continue to build on our line of rapid diagnostics,
we are expanding our focus to confirmatory testing, offering
customers an end-to-end diagnostic solution. Through our Maple
Biosciences division, we are en route to changing the face of
laboratory diagnostics with biosensor technologies, which will make
the routine laboratory tests of today obsolete, improving both the
delivery of healthcare and the patient experience.
Company:            Meissner Filtration Products, Inc.
Booth:             2469
Media Contact:         Karisa Koenig
Phone:             805-388-9911
E-mail:            karisak@meissner.com
Web:              www.meissner.com
From clinical trials through full-scale production, Meissner offers
leading filtration solutions for your process. Meissner Technical
Services (MTS) provides complete validation services, documentation &
customer support to select/size/install/maximize filtration systems.
Membrane filters (0.04-1.0 um absolute) include SteriLUX(R) PVDF,
STyLUX(R) and EverLUX(TM) PES, Chemdyne(R) Polypropylene (PP) and
Ultradyne(R) PTFE. Microfiber prefilters in ALpHA(R) PP, Protec(TM)
RF borosilicate glass and Protec(TM) RM dual-layer glass/PVDF
membrane & DeltaMax(TM)/DeltaDepth(TM) PP depth filters are offered.
Configurations include syringe filters, discs, capsules, high-
capacity UltraCap(R)/UltraCap(R) H.D. (Heavy Duty) capsules,
cartridges & DPS(TM) (Disposable Processing System) filter/bio-
container assemblies.
Company:            MetaMorphix, Inc.
Booth:             #490 - Maryland Pavilion
Media Contact:         Theresa Brady
Phone:             301.575.2505 C: 410.533.6328
E-mail:            tbrady@metamorphixinc.com
Web:              www.metamorphixinc.com
MetaMorphix is a leader in providing DNA analytical services to canine
registry organizations. These services include parentage testing and
pedigree certification. MMI Genomics, a wholly-owned subsidiary of
MetaMorphix, Inc., is the principal DNA analytical service provider
for the AKC and the UKC, the two largest breed registrations in the
United States.
The Canine Heritage (TM) Breed Test is the most recent product to come
from MMI's exclusive, state-of-the-art, SNP-based DNA technology. The
test genetically identifies the composition of mixed breed dogs.
Currently the test can identify 38 major breeds which make up
approximately 75% of the domestic canine purebred population.
Company:            Missouri Biotechnology Association
                (MOBIO) and Missouri Department of
                Economic Development
Booth:             2145
Media Contact:         Cheri Winchester
Phone:             636-262-8313
E-mail:            cwinchester@commongroundpr.com
Web:              www.mobio.org
From earning constitutional protection for stem cell research to
converting tobacco plants into cancer-fighting drugs, Missouri has
proven to be more than a fly-over state for biotechnology research.
For reporters interested in covering the latest agriculture and human
health advances courtesy of biotechnology research, we can connect
them with the people and organizations behind the breakthrough
science, addressing timely issues from biodiesel to the latest plant
biotech traits and stem cell research. Also learn why global biotech
institutions are investing several hundred million dollars in current
construction of new bioscience capital investments in Missouri.
Company:            MMG
Booth:             600
Media Contact:         Whitney Brimfield
Phone:             301-984-7191
E-mail:            mmg@mmgct.com
Web:              www.wegetpatients.com
At MMG, we focus on the best ways to identify sites and reach patients
for your clinical trials. During our 20-year history we've brought
together some of the nation's leading experts in clinical trial
recruitment and retention. Nobody understands patients, their
healthcare providers, and how to reach them like MMG.
Company:            MPI Research
Booth:             2273
Media Contact:         Peggy Foster
Phone:             269-668-3336 ext. 1817
E-mail:            Peggy.foster@mpiresearch.com
Web:              www.mpiresearch.com
MPI Research is a full service Contract Research Organization that
serves the biotech and the pharmaceutical industries in meeting their
nonclinical and early clinical drug development research needs, from
discovery to regulatory submission. Known for our state-of-the-art
facilities, excellent study quality, regulatory experience, AAALAC
accreditation, and GLP compliance, we partner with our Sponsors in
delivering on time, high quality, innovative and cost-effective
solutions. From single study protocols to multiple projects across
our broad scope of services, we have the capacity and resources to
start your studies promptly so that you can achieve your project
milestones. For complete information, visit our website at
www.mpiresearch.com.
Company:            MSOURCE
Booth:             Belgian Pavilion/Flanders BIO
Media Contact:         Adriaan Hart de Ruyter
Phone:             32 2 768 01 66
E-mail:            info@msource-cro.com
Web:              www.msource-cro.com
MSOURCE offers Clinical Insourcing & Outsourcing services across
Europe:
--Clinical Contract Hire
--Temporary staffing of qualified clinical research employees working
under MSOURCE contract
--Clinical Trial Management
--Phase I to IV clinical trials
--From Study design till Final Study report
--Clinical Data Management and Biostatistical Services
--Clinical Data Management for development and late phase trials
--Biostatistics and SAS programming
--Medical Writing
--Quality Assurance & Regulatory Consulting
--Consultants, trainers and auditors with strong clinical background.
--Pharmacovigilance and Medical Affairs
--EU CTD Compliant handling/reporting of SAE's
--Medical/Scientific consulting
Company:            Multiple Myeloma Research Foundation
Booth:             3221
Media Contact:         Anne Quinn Young
Phone:             203-652-0212
E-mail:            Quinnyounga@themmrf.org
Web:              www.multiplemyeloma.org
The mission of the MMRF is to invest urgently and aggressively in
research that will get treatments to patients as fast as possible and
ultimately find a cure for myeloma.
The MMRF supports one of the scientific community's most innovative
and responsive research grant programs. They are the #1 private
funder of myeloma-specific research worldwide, and will disseminate
$11 million in funding in 2007. Visit www.multiplemyeloma.org to
learn more.
Company:            Murphy & McManus, LLC
Booth:             533
Media Contact:         Robert Murphy
Phone:             781-444-3510
E-mail:            rmurphy@murphymcmanus.com
Web:              www.murphymcmanus.com
For more than 17 years, Murphy & McManus has assisted clients in
managing major capital projects to ensure budget, schedule, and
performance objectives are achieved and exceeded. Murphy & McManus is
a qualified Project Management firm with a staff of expert financial,
architectural, engineering, and construction professionals that
provide a multi-disciplined approach to executing a project. We have
developed a set of systems and controls to provide accurate and
effective planning, estimating, forecasting, and scheduling. Our
systems and expert advice enable our clients to make timely and
informed project decisions that are critical in the ultimate success
on a project.
Company:            National Jewish Medical and Research
                Center
Booth:             Colorado Pavilion #1483
Media Contact:         William Allstetter
Phone:             (303)398-1002
E-mail:            allstetterw@njc.org
Web:              http://www.nationaljewish.org
National Jewish, a private, nonprofit institution, and the #1
respiratory hospital in the US, conducts groundbreaking clinical and
scientific research in the fields of respiratory and allergic
diseases, inflammation, and immunology. National Jewish has close to
150 technologies in its active portfolio and owns 55 active issued
U.S. patents plus additional corresponding foreign patents. National
Jewish ranks in the top 5% of NIH funded institutions in terms of
dollars received every year and two HHMI-funded investigators are
part of our faculty. We actively seek commercial partners to
complement our clinical trial, research, & technology transfer
programs.
Company:            NeuroHealing Pharmaceuticals, Inc.
Media Contact:         Daniel Katzman
Phone:             617 331-4111
E-mail:            Daniel@neurohealing.com
Web:              www.neurohealing.com
NeuroHealing is developing therapies to improve the neuro-
rehabilitation process and functional outcome for patients who have
suffered debilitating injuries to the central nervous system.
Clinical stage programs include: NH001 (phase II), a dopaminergic
agent to help post traumatic brain injury patients to emerge from a
coma, vegetative or minimally consciousness state; NH004 (phase II),
an anticholinergic agent in a convenient intra-orally muco-adhesive
dissolving film to help treat Parkinson's and other motor neuron
disease patients who suffer from sialorrhea (drooling); and NH02D, a
novel mechanism compound to accelerate the rehabilitation outcomes of
stroke patients who remain with chronic motor and cognitive
disabilities.
Company:            Nevada Development Authority
Booth:             1807
Media Contact:         Riley Meredith,
                riley@preferredpublicrelations.com,
                (702) 254-5704
Phone:             888-4-NO-TAXES
E-mail:            info@nevadadevelopment.org
Web:              www.nevadadevelopment.org
The mission of Nevada Development Authority (NDA) is to attract,
retain and expand the business base and enhance the overall
socioeconomic environment of Southern Nevada. Established in Las
Vegas in 1956, NDA is Southern Nevada's largest economic development
agency and contributes to the area's prosperity by attracting new
companies and assisting local companies in expansion projects.
The Nevada Development Authority has successfully recruited more than
60 businesses to Las Vegas this past fiscal year, including high
tech, communications and life science companies. Currently, NDA is
implementing a campaign to recruit bio tech and life science
businesses on the east coast.
Company:            New Jersey Research Universities
Booth:             1122
Media Contact:         Judith Sheft
Phone:             973-596-5825
E-mail:            sheft@njit.edu
Web:              www.njit.edu / www.rutgers.edu /
                www.princeton.edu / www.umdnj.edu
New Jersey offers a rich academic environment, housing prestigious
colleges and universities and advanced technology development
centers. New Jersey Institute of Technology, Princeton University,
Rutgers University, the state university of New Jersey and University
of Medicine and Dentistry of New Jersey comprise core components of
the state's academic research and technology development
infrastructure. These universities deliver advances in complementary
areas of scientific discovery in the public interest. Successful
public/private/academic collaborations have helped support the growth
of the state's position as a leader in health care. Areas of key
expertise include work in biomedical engineering, neuroscience,
nanotechnology, stem cell research, and pharmaceutical engineering.
Company:            Next Generation Clinical Research
Booth:             1145 - Wisconsin Pavilion
Media Contact:         Matthew Hanson
Phone:             608-835-5811
E-mail:            mhanson@nextgenclinical.com
Web:              www.nextgenclinical.com
Next Generation is a Contract Research Organization (CRO) that
provides clinical trial management, monitoring, data management,
regulatory affairs and management services to small and mid-sized
pharmaceutical and biotechnology organizations. Our specialties
include complex projects and trial designs or unique delivery methods
in multiple therapeutic areas. We command particular expertise in
Nephrology, Bone Disease, Dermatology and Central Nervous System
disorders.
Company:            NH, State of & Public Service of NH
Booth:             2133.
Media Contact:         John R. DiNapoli, Business Development
                Manager
Phone:             603-271-2591 X 114
E-mail:            jrdinapoli@dred.state.nh.us
Web:              www.nheconomy.com
NH, State of and Public Service of NH work together in attracting
businesses to NH. Our organizations, along with others (business,
government and education) assist companies in creating jobs. Contact
our offices for additional details on how your company can benefit by
locating/expanding to NH today at (603) 271-1591 or 634-2386
www.nheconomy.com or www.psnh.com
Company:            NHS Innovations London
Booth:             1864
Media Contact:         Laura James
Phone:             44 (0)207 380 1711
E-mail:            laura.james@nhsinnovationslondon.com
Web:              www.nhsinnovationslondon.com
The NHS is the UK's main healthcare provider and its biggest employer
of science graduates. It is the 3rd largest organisation in the world
and is the biggest recruiter in Europe. As a service with technology
at its forefront the NHS is a significant source of healthcare
innovations. These innovations fulfill real needs, originating from
the day-to-day provision of healthcare.
NHS Innovations London identifies, protects and commercialises the
ideas and research of over 65 NHS Hospital Trusts in London including
hospitals specialising in cancer, cardiology, heart & lung disease,
pediatrics, psychiatric medicine, acute & trauma services and
neurosciences with many having world class research facilities and
laboratories. NHSIL manages innovations competitions and undertakes
IP audits to identify potential inventions. The assessment and
development of these technologies is crucial to their success and our
best practice evaluation, protection, development and
commercialisation process results in a pipeline of technologies with
decreased risk and increased value.
Innovations from the NHS span the healthcare industry and include
Therapeutics, Diagnostics, Informatics, Medical Devices, Assistive
Technologies, Equipment and Surgery
Company:            NicOx
Ticker Symbol & Exchange:   Bloomberg ticker: COX:FP / Reuters
                ticker: NCOX.PA (EuroNext)
Media Contact:         Irene Lalande
Phone:             33 (0)4 97 24 53 11
E-mail:            lalande@nicox.com
Web:              http://www.nicox.com
NicOx is a product-driven biopharmaceutical company dedicated to the
development of nitric oxide-donating drugs to meet unmet medical
needs. NicOx is targeting the therapeutic areas of inflammatory and
cardio-metabolic diseases. Resources are focused on two lead
compounds, naproxcinod, in phase 3 development for the treatment of
osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx
has strategic partnerships with some of the world's leading
pharmaceutical companies, including Pfizer Inc. and Merck and Co.,
Inc.
NicOx S.A. is headquartered in Sophia-Antipolis, France, and is a
public company listed on the Eurolist of Euronext Paris (segment:
Next Economy).
Company:            NPIL Pharma Torcan
Booth:             507
Media Contact:         Nicole Tingley
Phone:             416.904.4735
E-mail:            Nicole.tingley@torcan.com
Web:              www.npilpharma.com or www.torcan.com
NPIL Pharma is the new global brand in custom manufacturing of RSM,
key intermediates, active pharmaceutical ingredients and finished
products with operations in India, the UK and Canada.
NPIL creates value across the entire drug development lifecycle by
offering integrated services to support preclinical development
through to commercialization.
NPIL offers a comprehensive range of chemistry and formulation
development services to support preclinical and clinical development.
With extensive large-scale assets, including high potency
manufacturing, NPIL also offers a flexible, cost-effective commercial
pharmaceutical manufacturing services
NPIL Pharma is one of the very few CMO's in the world forward
integrated from API/Intermediates development and manufacturing into
final dosage forms.
Company:            Norac Pharma
Booth:             1676
Media Contact:         Kirsten Johnson
Phone:             626-812-5538
E-mail:            kjohnson@norac.com
Web:              www.noracpharma.com
Norac Pharma is a Contract service company who handles outsourcing of
API Manufacture, Process Development, and Analytical services.
Centrally located in California, we are the ideal partner for local
companies seeking to outsource API production.
With almost five decades of experience in manufacturing APIs, and
expertise in the production of Controlled Substances and Potent
Compounds, Norac Pharma delivers a timely, efficient, and compliant
product.
Company:            North Carolina Biotechnology Center
Booth:             1655
Media Contact:         Jim Shamp, News and Publications Editor
Phone:             919-541-9366
E-mail:            Jim_shamp@ncbiotech.org
Web:              www.ncbiotech.org
The North Carolina Biotechnology Center is a private, non-profit
corporation established in 1984 as the world's first government-
sponsored biotechnology initiative. Its mission is to provide long-
term economic and societal benefits to North Carolina by supporting
biotechnology research, business and education statewide.
Headquartered in Research Triangle Park, the Center has five small
offices across the state to encourage regional and niche development
of biotechnology. The Center is supported by the state's General
Assembly and has a budget is $17.6 million and a staff of 65.
North Carolina has the nation's third largest biotechnology industry
with 350 bioscience companies employing 48,000 people. Visit
www.ncbiotech.org.
Company:            North Carolina Department of Commerce
Booth:             Pavilion 1655
Media Contact:         Mira Meghdessian
Phone:             646-351-3510
E-mail:            mira.meghdessian@dc-intl.com
Web:              www.nccommerce.com
North Carolina: The State of Minds. North Carolina's knowledge-based
workforce, combined with a network of support organizations focused
on collaboration, offers many strategic advantages for the
biotechnology, pharmaceutical, and life science industries. Over 350
bioscience companies employ 48,000 people in the state. And North
Carolina provides innovative programs to train and replenish this
talent pool.
The North Carolina Community College System, the largest per capita in
the nation, provides specialized training through its BioNetwork
initiative. The North Carolina Biotechnology Center is the world's
first government-sponsored organization dedicated to developing the
biotechnology industry.
Learn more at the North Carolina Pavilion (#1655).
Company:            NOTOX B.V.
Booth:             2633
Media Contact:         marketing@notox.nl
Phone:             31736406700
E-mail:            marketing@notox.nl
Web:              www.notox.nl
NOTOX B.V. is a leading contract research organization, providing full
safety, toxicology and consultancy services for the pharmaceutical
industry, non-clinical testing, in vitro / in vivo toxicology,
kinetics and metabolism studies.
Toxicology research is supported by an extensive (bio-)analytical
laboratory facility, method validation and metabolite identification.
NOTOX has over 70 scientific and regulatory advisors with many years
of experience in the non-clinical development of NCE's and
biologicals. Our consultants, scientists and project coordinators,
use their knowledge and experience to design complete programs for
each specific compound from lead to Phase I clinical trial. NOTOX
B.V. is part of a world wide group of autonomous companies providing
toxicology research services for the pharmaceutical industry. NOTOX,
Dedicated Crystal Clear
Company:            Nucleus Network
Booth:             #1515
Media Contact:         Maria Chiam
Phone:             415 606 5839
E-mail:            m.chiam@clinicaltrialsconsulting.com.au
Web:              www.nucleusnetwork.com.au
Quality driven clinical trials conducted on-time and on-budget in
Australia for biotech, pharma and medical device companies. Services
include:
--Specialised Phase I and early phase capabilities;
--24 bed state-of-the-art in-patient facilities for early phase
studies with access to diverse patient and volunteer populations;
--Continuous cardiac monitoring (telemetry);
--Clinical trial consulting services to create a full clinical
development plan and regulatory filings for clinical trial approval
and marketing authorisation for Australian and international agencies
such as TGA, FDA and EMEA;
--Commercial sponsorship for international companies without a
corporate presence in Australia available.
Company:            NYC Economic Development Corporation -
                Bioscience Desk
Booth:             1833
Media Contact:         Bill Fair, Managing Director
Phone:             212 312 3836
E-mail:            bfair@nycedc.com
Web:              www.nycbiotech.com
Mayor Bloomberg has made bioscience a key priority and projects being
addressed by NYC's Bioscience Desk include the East River Science
Park. New York City unique bioscience assets include:
--Talent - NY metro area has the largest bioscience workforce
--Research - $1.3B in NIH awards and the largest concentration of
academic institutions
--Funding - Wall Street access and 125 healthcare venture capital
firms
--Lab/Office Space - office, sales and research labs are here. ERSP
will feature 1.1 M sf of offices/labs
--More international flights than any US City
--115 bioscience firms recognize the advantage of their NYC location
Company:            NYCOMED
Booth:             hospitality suite at Westin Waterfront
                Hotel (adjacent to Convention-centre)
Media Contact:         Morten Faester
Phone:             45 4056 6888
E-mail:            MOR@nycomed.com
Web:              www.nycomed.com
NYCOMED is the European specialty pharma which recently acquired
Altana-Pharma.
NYCOMED is active in licensing-in of mid-stage projects for co-
development and European commercialization -- as well as out-
licensing a couple of late-stage projects for US-partnering.
The therapeutic focus areas includes: Pain-management, Hospital
cardiology, Respiratory, GI, Osteoporosis and Surgery-management.
Amongst the out-licensing opportunities available are the "Instanyl"
nasal fentanyl for breakthrough pain.
Company:            Ocimum Biosolutions
Booth:             Booth No.# 2500
Media Contact:         Ashwin Sivakumar
Phone:             00 91 40 66627200-04
E-mail:            ashwin.s@ocimumbio.com
Web:              http://www.ocimumbio.com
Ocimum Biosolutions is a leading integrated life-sciences R&D enabling
company providing focused solutions for enabling different steps of
the life-sciences process chain. Our strategic presence in USA,
Netherlands and India helps us offer cutting edge technologies at
competitive market rates.
Our BioMolecules division provides complementary product lines in
Microarrays and Oligos using sophisticated proprietary technologies
while adhering to strict quality standards. Through our Ocichip(TM)
technology, we offer one of the widest ranges of catalog arrays and
flexible custom arrays with superior probe design. We offer QUTE
(Quantitativel Unique Technique Extracted) oligos with stringent
quality controls using proprietary purification technology which is
in par with HPLC.
Our Bioresearch division with sophisticated world-class facilities
offers a variety of analytical research services in the Molecular
Biology space ranging from Sequencing services to gene synthesis.
Our BioIT division provides flexible end to end solutions for
management and analysis of complex biological data.
Company:            OmniLingua Inc
Booth:             2372
Media Contact:         Tracie Williams
Phone:             319-892-8119
E-mail:            twilliams@omnilingua.com
Web:              www.omnilingua.com
OmniLingua Inc, as your globalization management partner, will assist
you in developing your global presence, reducing your time to market,
and minimizing your risk in new markets. Our precise balance of
highly skilled industry-specific experts, global technology systems
professionals and the power of the OTIS(TM) Management System -
proven personnel, processes and tools - can be implemented
successfully in any cultural environment. We ensure that your
globalization management needs are fulfilled accurately and at the
lowest cost over the long-term. At OmniLingua our focus is crystal
clear - delivering focused globalization management quality, service
and technology to achieve your global service needs.
Company:            Oncolytics Biotech Inc.
Ticker Symbol & Exchange:   NASDAQ:ONCY, TSX:ONC
Media Contact:         Cathy Ward
Phone:             403.670.7370
E-mail:            cathy.ward@oncolytics.ca
Web:              www.oncolyticsbiotech.com
Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary
product, REOLYSIN(R), as a potential therapeutic for a wide variety
of human cancers.
Oncolytics has completed six clinical trials with REOLYSIN(R) in
Canada, the U.K. and the U.S. and is currently conducting or has
approval to commence seven Phase I or Phase II REOLYSIN(R) trials in
the U.K. and the U.S.
The current clinical program includes local or systemic delivery of
REOLYSIN(R) as a monotherapy, and local or systemic delivery of
REOLYSIN(R) in combination with radiation or chemotherapy for
patients with advanced cancers.
Company:            Onondaga County - Syracuse NY
Booth:             1833
Media Contact:         Greg Hitchin
Phone:             315-435-3770 or 315-427-8583 (at show)
E-mail:            ghitchin@ongov.net
Web:              www.SyracuseCentral.com
Syracuse and Central New York is a great place to do business! Known
as a center of innovation since the 19th century, the community
maintains the spirit of innovation while transforming itself into a
success in the new economy. Two new initiatives, the CNY
Biotechnology Research Center and the Center of Excellence for
Renewable Energy will help fuel the regions continued success. A
highlight of the area is the new 250-acre Life Science business park.
Located in a suburban section of Onondaga County, the Park features
the seclusion of a rural setting with easy access to housing,
shopping, and airport.
Company:            Open Biosystems, Inc.
Booth:             Alabama Pavilion/ 1742
Phone:             256-704-4848
E-mail:            info@openbiosystems.com
Web:              www.openbiosystems.com
Open Biosystems offers products that span Genomics, RNAi and
Antibodies. Building on the rapid sharing model that is at the core
of the Human Genome Project, Open Biosystems collaborates with some
of the most innovative life science investigators working today. We
partner with them to bring to market new products--they have often
pioneered the new resources in their own lab, and we prepare it for
widespread use and then provide access to the research community.
We offer the most complete library or genes in the industry. This
novel library consists of several full length cDNA and open reading
frame collections.
Company:            Optimata
Booth:             Israeli Pavilion (3171)
Media Contact:         Guy Malchi, CEO
Phone:             972-3-7519226
E-mail:            info@optimata.com
Web:              www.optimata.com
Optimata is a modeling based biopharma company that develops
computerized tools, Virtual Patient engines, for navigating drug
development towards better drugs, faster.
Applying biomathematics to develop a predictive bio-simulation
software toolkit, this technology provides a comprehensive drug
development solution.
It thoroughly unfolds drug patient dynamic interactions, enabling drug
developers to perform rapid virtual clinical trials and to forecast
optimal drug regimen patient population clinical indication match for
a given trial end point.
Optimata's Technology Enables
--Drug repurposing
--Enhanced drug competitive profile
--Early "GO/NO-GO" development decisions
--Drug safety profile
--Optimal dosing schedules
--Clinical indication selection/expansion
Company:            OpStat Group Inc.
Booth:             1371 in Connecticut Pavilion
Media Contact:         Jim Curry
Phone:             203.431.3905
E-mail:            JimCurry@OpStat.com
Web:              www.OpStat.com
With 20-years biopharma experience, OpStat has developed models for
capacity, performance and cycle time improvement in manufacturing and
laboratory operations. OpStat's simulations and methodology analyze
alternatives for equipment, inventory and staffing for R&D, clinical
trials, tech transfer and commercial production.
Covering the full scope of the supply chain from cell fermentation,
formulation, filling, to packaging, the models include all forms of
products - including liquids, solids, lyophilized vials and syringes,
transdermals and specialized delivery. Detailed processing,
decontamination and cleanout rules provide real-world predicted
results.
Laboratory models with attribute test profiles may be used for stand-
alone planning or integrated into manufacturing flows.
Company:            Orion Corporation
Booth:             2065 Scandinavia Pavilion
Ticker Symbol & Exchange:   ORNAV, ORNBV (OMX, Helsinki)
Media Contact:         Tuula Laitinen, Communications Manager
Phone:             358 50 966 2136
E-mail:            tuula.laitinen@orion.fi
Web:              www.orion.fi
Orion Corporation Orion Pharma is competent in R&D to take products
from discovery to MA. Therapy areas CNS, CV and HTU. We provide
supportive partnership with the early stage projects. We look for
strategic partnerships with universities and companies. Our business
includes research, manufacturing and marketing, Northern Europe as
home territory.
Company:            Otsuka Pharmaceuticals - ODPI Division
Booth:             1884
Media Contact:         Mr. Koji Yoneda, Director, BD
Phone:             81-6-6231-7158
E-mail:            odpiweb@otsuka.jp
Web:              http://otsuka-odpi.com
Otsuka Pharmaceutical Co., Ltd. has developed a new DPI System (ODPI
System) utilizing a unique lyophilizing technique, by which the
company has efficiently formulated proteins, peptides, and chemicals
and achieved the easy inhalation of these drugs. The ODPI System
comprises a freeze-dried formulation with novel excipients, and a
unique yet simple manufacturing method, and a compact and easy-to-use
inhalation device. Differing from conventional inhalation systems
that require prior pulverization of the drug, the ODPI System
achieves micronization of the drug substance with the air impact of a
single intake of breath, enabling simultaneous micronization and
inhalation.
Company:            PAA Laboratories Inc.
Booth:             1181
Media Contact:         Mark Ferreira
Phone:             508-984-5881
E-mail:            USinfo@paa.com
Web:              www.paa.com
PAA specializes in the manufacture and worldwide distribution of cell
culture products for research, development, diagnostic and
biopharmaceutical production. The company processes and manufactures
animal & human sera, synthetic media, protein-free media, biochemical
supplements and reagents, all of which are used as cell nutrients in
cell culture technology. PAA is a privately held company with sales
in excess of 32M Euros, with manufacturing operations in Europe,
North America and Australia, and sell products in over 40 countries
world-wide through direct sales and distributors.
Company:            PaleoTechnology International
Booth:             1620
Media Contact:         Bevo Beaven, CTA Integrated
                Communications
Phone:             (303) 665-4200
E-mail:            bevo@ctaintegrated.com
Web:              www.ctaintegrated.com
PaleoTechnology International is a technology development and
commercialization company creating bio-based products and processes
that increase the value derived from natural resource environments.
This happens through innovative Bio/Chemical Discovery and Bioprocess
Development in diverse environments including petroleum extraction
sites, extreme environments, and in zones of significant
biodiversity. These specialty products and processes represent the
highest and best use of resources from these environments, and
contribute to solving global problems associated with existing
technologies.
PaleoTechnology, in partnership with the Box Hill Institute in
Melbourne, Australia will collaborate on the development of novel
products and bioprocesses derived from diverse natural resource
environments.
Company:            Palm Beach Gardens, Florida
Booth:             1073
Media Contact:         Dolores Key
Phone:             561.799.4136
E-mail:            bio@pbgfl.com
Web:              www.pbgfl.com
With cosmopolitan flair and hometown feel, Palm Beach Gardens is your
passport to a superb quality-of-life: average sunny temperature of 78
degrees F; proximity to two international airports; beautiful parks
and preserves; pristine area beaches; fine shopping and dining; and
home of Scripps Florida.
Located on Florida's east coast, Palm Beach Gardens is the epicenter
of a burgeoning business community and is home to many notable
corporate headquarters: the newest campus of Bascom Palmer Eye
Institute, Anspach Companies, 3i, and TransDermal Technologies,
compliment the scientific environment.
The Gardens - your ticket to an environment that nurtures success.
Company:            PAREXEL International Corporation
Booth:             533
Ticker Symbol & Exchange:   NASDAQ Exchange: PRXL
Media Contact:         Rebecca Passo, SHIFT Communications
Phone:             617-779-1817
E-mail:            rpasso@shiftcomm.com
Web:              www.PAREXEL.com
PAREXEL International Corporation is a leading global
bio/pharmaceutical services organization, providing a broad range of
knowledge-based contract research, medical communications and
consulting services to the worldwide pharmaceutical, biotechnology
and medical device industries. PAREXEL will be sponsoring and
exhibiting its range of developmental and commercialization services
at the 2007 BIO International Convention in the MBC Massachusetts
Pavilion, the largest state pavilion. PAREXEL is a Massachusetts
Biotech Council (MBC) member and Massachusetts-based, international
company. Visit PAREXEL's Booth #533 to learn about the Company's
continuing focus on small/emerging biopharmaceutical companies and
view a demonstration of its advanced technologies by PAREXEL's
subsidiary, Perceptive Informatics.
Company:            Partnership for Biotechnology Research
                (PBR)
Booth:             AL pavilion
Media Contact:         Amanda Wallace
Phone:             256-319-1420
E-mail:            info@alpbr.org
Web:              www.alpbr.org
The Partnership for Biotechnology Research (PBR), a not-for-profit
organization, catalyzes and supports the biotechnology
entrepreneurial and educational efforts in Huntsville, Alabama.
Through quarterly events, PBR highlights national speakers and local
research efforts. Activities focus on developing the current and
future biotechnology workforce. Established in 2003, PBR now consists
of over 250 people from Greater Huntsville. Members range from
biotechnology entrepreneurs and employees, to university students and
faculty, to a wide range of service and support providers. Visit
www.alpbr.org, PBR's online community, for local press releases,
details and photos of PBR's events and activities and local job and
resume postings.
Company:            PCI Synthesis
Booth:             533 / A26
Phone:             978-463-4810
E-mail:            sales@pcisynthesis.com
Web:              www.pcisynthesis.com
PCI Synthesis is a specialty chemical company that manufactures API's
and custom chemicals for pharmaceutical, biotech and medical device
companies. PCI offers a full complement of process research,
development and manufacturing services from single grams to metric
tons.
PCI has the proven ability to navigate the regulatory processes with
its cGMP manufacturing status and DMF submissions. The company is
harmonized to the ICH guidelines and is Part 11 7a compliant. PCI has
undergone both general site and pre-approval inspections from the FDA
at its manufacturing plant in Newburyport, MA and its research center
in Devens, MA facilities.
Company:            Pennsylvania Bio
Booth:             Pennsylvania Pavilion - Booth 1440
Media Contact:         Karla White
Phone:             610-578-9220
E-mail:            karla@pennsylvaniabio.org
Web:              www.pennsylvaniabio.org
Pennsylvania Bio is the Voice of Advancement for the biosciences
community in Pennsylvania, representing the continuum of the
industry--research institutions; emerging biotech, device, and
diagnostic companies; global pharmaceuticals; and support
organizations. Pennsylvania Bio serves as a point of contact for
information on the bioscience industry in Pennsylvania, including
industry trends, the industry's impact on the commonwealth's economy,
workforce initiatives, and public policy and its impact on the
biosciences.
Company:            Pennsylvania Department of Community
                and Economic Development
Booth:             Pennsylvania Pavilion, Booth 1440
Media Contact:         Ted Martin
Phone:             717-720-1388
E-mail:            themartin@state.pa.us
Web:              www.newpa.com
Pennsylvania is the center of life science innovation --world-class
basic research, emerging companies, mature industry, global
pharmaceuticals and support organizations. Our $2 billion Life
Sciences Enterprise commitment and $2.8 billion Economic Stimulus
program are unrivaled. Make your business investment succeed. Put
Pennsylvania in your future.
Pennsylvania Department of Community and Economic Development
Commonwealth Keystone Building
400 North Street, 4th Floor
Harrisburg, PA 17120
800-237-4363
www.newPA.com
Company:            Pennsylvania State University, The
Booth:             1440 - Pennsylvania Pavilion
Media Contact:         Bill Mahon
Phone:             814-863-1028
E-mail:            bmahon@psu.edu
Web:              http://www.psu.edu
Penn State offers research partnering, training, and educational
opportunities in medical devices; drug delivery and discovery;
biomaterials; nanobiotechnology; bioinformatics; pharmaceutical and
health industry management; and bio-based materials and products for
agricultural applications. The Penn State Industrial Research Office
(www.iro.psu.edu) is available to assists companies in accessing
these opportunities through the Hershey Medical Center, The Huck
Institutes of the Life Sciences, Materials Research Institute, and
College of Agricultural Sciences.
Company:            PerkinElmer Life and Analytical
                Sciences
Booth:             2202
Ticker Symbol & Exchange:   NYSE symbol: PKI
Media Contact:         Sigrid Tehrani
Phone:             508-241-2697
E-mail:            Sigrid.tehrani@perkinelmer.com
Web:              Perkinelmer.com
PerkinElmer's OneSource is a business improvement solution that
provides the skills and capabilities necessary to enable Scientists
to focus on Science. Our one-contact, one-contract solutions lower
costs, increase productivity and enhance regulatory compliance.
OneSource offers scalable, tailored business solutions for all lab
equipment maintenance and asset management activities. Through
consolidated and proactive management, OneSource provides customers
with better control of their maintenance costs and improves
laboratory productivity through increased uptime. For additional
information about OneSource, contact PerkinElmer at (781) 663-6900.
Company:            Perkins Coie LLP
Booth:             1266
Media Contact:         Julie Kaplan
Phone:             310.788.3287
E-mail:            JLKaplan@perkinscoie.com
Web:              www.perkinscoie.com
Perkins Coie serves great companies ranging in size from FORTUNE 100
companies to start-ups. The firm has more than 600 attorneys in 15
offices across the United States and in China and has historically
represented market leaders in traditional and cutting-edge technology
industries. We employ a multidisciplinary approach to provide a
comprehensive range of legal services to life sciences clients at
every stage of growth.
Company:            PIERRE FABRE MEDICAMENT Active
                Ingredients Division
Booth:             1424
Media Contact:         Yann BAYEUX
Phone:             33.563.81.24.00
E-mail:            Yann.bayeux@pierre-fabre.com
Web:              www.plantes-industrie
PFM - active ingredients division, is focused on new process
development, industrialization and commercial production of cGMP
APIs. We are active in cytotoxic APIs : vinorelbine, vinflunine,
etoposide etc... We are also highly skilled in natural product
extraction and purification. We are equipped with continuous
extraction chains to extract up to 1t/h of dried plant. The material
can then be purified by HPLC (450mm) and some chemical steps can be
added. Based on our know-how in SuperCritical Fluids, we have
developed a multi-purpose technology platform : Nanoparticles,
FORMULPLEX(R) and FORMULCOAT(R) used in bioavailability/solubility
enhancement, taste masking or micronization.
Company:            Pittsburgh Regional Alliance
Booth:             1440 - Pennsylvania Pavilion
Media Contact:         Bernie McShea
Phone:             412-260-6464
E-mail:            bmcshea@pittsburghregion.org
Web:              www.pittsburghregion.org
The Pittsburgh Regional Alliance is the regional economic development
and investment promotion agency for the Pittsburgh, Pennsylvania
area. We maintain close relationships with leading life sciences
companies in our region such as Medrad, Bayer, Respironics, and
Cellomics, and have assisted in locating and expanding them in our
region. We are quite knowledgeable about life sciences investment
trends in our region, both among private companies as well as world-
class research institutions (e.g., University of Pittsburgh,
Carnegie-Mellon University).
Company:            PharmaCell
Booth:             Netherlands Pavilion #2633
Media Contact:         Maurice M.M. Horsten, VP Marketing &
                Sales
Phone:             31-43-3509910
E-mail:            m.horsten@pharmacell.nl
Web:              www.pharmacell.nl
PharmaCell is a Life Science company providing know-how and resources
for product an process design combined with GMP manufacturing in its
own facility. PharmaCell is located in the Biopartner Center
Maastricht and, therefore, can take advantage of an extensive network
to mediate in R&D, financing and housing requirements of the clients.
Close cooperation with the Maastricht University and the associated
Academic Hospital gives PharmaCell the unique capability to provide
support and/or partnership to R&D companies to bring new products
from the lab into the clinic.
Company:            PLANET LLC
Booth:             1133
Media Contact:         Ms. Marty Gustafson
Phone:             608-827-5555
E-mail:            gustafsonm@hypercosm.com
Web:              www.planet-lcc.com
PLANET LLC strives to transition technologies from initial development
stages to viable commercial markets. Under a strategic alliance with
Orbital Technologies Corporation, PLANET LLC has advanced space-based
technologies into products for the life sciences, education, space
resources, and biomedical markets. Offerings include LED lighting,
plant-growth systems, lunar simulant, web-based 3D software and
physical rehabilitation.
PLANET LLC is currently focused on the commercialization of controlled
environment capabilities into controlled agricultural manufacturing
for new products such as medicines, nutraceuticals, and other protein
chemistry that utilize plants as key step in production.
Company:            Praxair, Inc.
Booth:             1007
Ticker Symbol & Exchange:   PX (NYSE)
Media Contact:         Hope Dipierro
Phone:             203-837-2573
E-mail:            Hope_dipierro@praxair.com
Web:              www.praxair.com/biopharma
Praxair supports key stages in the lifecycle of biopharma product
development, assuring consistent quality, efficiency and
reproducibility from discovery to scale-up to production.
Praxair, Inc. is the largest industrial gases company in North and
South America, and one of the largest worldwide, with 2006 sales of
$8.3 billion. The company produces, sells and distributes atmospheric
and process gases, and high-performance surface coatings. Praxair
products, services and technologies bring productivity and
environmental benefits to a wide variety of industries, including
aerospace, chemicals, food and beverage, electronics, energy,
healthcare, manufacturing, metals and others. More information on
Praxair is available at www.praxair.com
Company:            Primorigen Biosciences LLC
Booth:             1139
Media Contact:         Chuck Oehler
Phone:             608-441-8334
E-mail:            info@primorigen.com
Web:              www.primorigen.com
Primorigen Biosciences LLC is a leader in developing fluorescent,
multiplexed immunoassays for detecting protein biomarkers for cell
therapy research and other applications. The company offers complete
contract capabilities for rapid monoclonal antibody development,
custom assays and microarrays, cDNA cloning, protein
expression/purification, and automated statistical design of
experiment optimization. Partnering interests include match pair
antibodies, novel substrates and slides for microarrays, systems for
protein quantification and total cell characterization, novel
detection systems, and related technologies. Primorigen's scientists
come from leadership roles at some of the world's prominent
biotechnology companies. The company recently expanded operations at
University Research Park in Madison, WI.
Company:            ProNAi Therapeutics, Inc.
Media Contact:         Mario Fante, Aviator PR
Phone:             617-763-9887
E-mail:            mario@aviator-pr.com
Web:              www.pronai.com
ProNAi Therapeutics, Inc. is a biopharmaceutical drug development
company pioneering a new class of nucleic-acid drugs based on DNA
interference (DNAi(R)), which employs single strands of DNA to target
and treat non-transcribed regions of genomes responsible for complex
genetic diseases. ProNAi is developing multiple DNAi(R) drug
candidates with the potential to treat multiple cancers, including
non-Hodgkin's lymphoma, prostate, breast, and colon cancers. The
company's lead drug candidate, PNT2258, which has demonstrated in
vivo efficacy in a variety of human tumor xenograft models, is
currently in preclinical development. ProNAi is also exploring the
potential of DNAi(R) therapies for indications beyond oncology.
Company:            Pronota nv
Booth:             Stand 3033, Belgium Pavilion
Media Contact:         Sofia Vindevogel
Phone:             32 9 241 11 64
E-mail:            Sofia.vindevogel@pronota.com
Web:              www.pronota.com
Pronota, the Belgium-based protein biomarker company, is developing a
new generation of diagnostic and pharmacodiagnostic products based on
protein biomarkers. The Company's advanced technology identifies
protein biomarkers in biological samples that provide insight in
disease etiology. It can also identify protein biomarkers that
distinguish between patients that will and will not respond to
certain drugs to determine best treatment options. Pronota also
provides contract research services for protein biomarker discovery
to pharmaceutical and diagnostic companies.
To find out more about Pronota and its exciting developments in the
protein biomarker field, come and talk to Koen Kas, Chief Scientific
Officer, at stand 3033.
Company:            ProTecs
Booth:             Pennsylvania Pavilion Booth #1440
Media Contact:         Christopher R. DiPaolo
Phone:             610-941-1001 ext.380
E-mail:            cdipaolo@protecsinc.com
Web:              www.protecsinc.com
ProTecs is a technically based professional services company providing
program/project management, construction management, commissioning
and integrated design/build services to emerging, small and mid-size
biotechnology, pharmaceutical, medical device, healthcare, higher
education and technology based companies. ProTecs was founded in 2005
to provide creative, value-driven approaches and entrepreneurial
solutions to help companies bring their products to market in the
most cost effective and timely manner. ProTecs aligns themselves with
their clients' stated long-term strategic business objectives to meet
their process, compliance, financial and time to market goals.
Company:            Protein'eXpert
Booth:             2057 - France Pavillion
Media Contact:         Christelle Dagoneau, Business
                Development Director
Phone:             33 438 023 650
E-mail:            marketing@proteinexpert.com
Web:              www.proteinexpert.com
Funded in 2000 in Grenoble, France, Protein'eXpert is an expanding CMO
devoted to recombinant protein engineering & production for
biomedical research applications. Our 36-staff company offers custom-
designed services focusing on the discovery, optimisation and
production of valuable target or therapeutic proteins. Since 2004,
Protein'eXpert has extended its offering to the cGMP biomanufacturing
of therapeutic protein products for early clinical trials via its
integrated subsidiary PX'Pharma. The combination of Protein'eXpert
and PX'Pharma know-how and manufacturing capacities allows ensuring a
seamless transfer from therapeutic protein development up to clinical
production stages.
Company:            Proteologics
Media Contact:         Mrs. Anna Khazanov
Phone:             972-8-9475666
E-mail:            anna@proteologics.com
Web:              www.proteologics.com
Proteologics to present at the 2007 Business Forum.
Proteologics is a leading force in translating the ubiquitin system
into novel therapeutics. Drs. Avram Hershko and Aaron Ciechanover -
the Nobel Prize laureates for the discovery of the ubiquitin system-
chair the company's scientific advisory board.
Proteologics' Rational Target & Drug Discovery Platform has already
yielded several drug discovery programs, in antivirals, cancer and
CNS.
Proteologics is looking for strategic partners that like to benefit
from Proteologics' unique expertise in target discovery, assay
development & drug discovery in the ubiquitin system as well as in
lead development and siRNA technology.
Company:            Quincy Bioscience, LLC
Booth:             Wisconsin Pavilion
Media Contact:         Dakota Miller
Phone:             608-233-2475
E-mail:            dmiller@quincybioscience.com
Web:              www.quincybioscience.com
Quincy Bioscience is a biopharmaceutical company focused on the
discovery, development and commercialization of novel medicines to
treat the diseases of aging. The company's therapeutic products focus
on alleviating the consequences of impaired calcium homeostasis - the
imbalance of calcium ions commonly thought to be related to
neurodegenerative diseases such as Alzheimer's and Parkinson's.
Quincy Bioscience is set apart by its cutting-edge applications of
the calcium-binding protein aequorin, breaking new ground in the
fight against age-related disease. Quincy Bioscience has also
successfully developed the dietary supplement Prevagen(TM)
(www.prevagen.com) and is launching this product on September 1,
2007.
Company:            Qserve
Booth:             Hall C, stand 2633
Media Contact:         W.W.M. Driessen
Phone:             31 20 410 1250
E-mail:            info@qservegroup.com
Web:              www.qservegroup.com
Qserve(R) is an independent medical device regulatory consulting firm
with offices in the Netherlands and USA. Qserve has considerable in-
house expertise in the areas of life science, medical device,
biotechnology and regulatory compliance consulting, which include
strategic approach, due diligence & GAP analysis, product compliance,
pre-clinical, training, auditing and quality management systems
implementation.
Company:            Q Therapeutics, Inc.
Booth:             Utah Pavilion #2707
Media Contact:         Deborah Eppstein
Phone:             801-556-5004
E-mail:            deppstein@qthera.com
Web:              www.qthera.com
Q Therapeutics has taken an innovative and practical approach to
developing products to treat currently untreatable, debilitating
diseases of the central nervous system. Q-Cells(TM) is a cell-based
therapeutic that does naturally what no other drug can - it replaces
the insulating myelin on damaged neurons and thus regenerates normal
function of these neurons. Q-Cells are applicable to a wide range of
demyelinating diseases, including MS, cerebral palsy, spinal cord
injury and white matter stroke.
Company:            Quebec Government
Booth:             1020
Phone:             514 499-2199, ext. 3310
E-mail:            nancy.carignan@mdeie.gouv.qc.ca
Web:              Mdeie.gouv.qc.ca/bio2007
Discover the advantages of investing and doing business in Quebec, a
world-leader in life sciences and stand a chance to win a free
weekend at the Montreal International Jazz Festival. At Quebec
Pavilion, booth 1020, meet specialists who will explain why your
expansion projects should be carried out in Quebec. In private
meeting rooms you will learn about fiscal incentives, financing,
wage-competitive talent, etc. In Quebec we grow creativity and build
on talent. www.mdeie.gouv.qc.ca/bio2007
Company:            Queensland Government
Booth:             Australia Pavilion (1515)
Media Contact:         Elouise Campion
Phone:             61 7 3224 6784
E-mail:            elouise.campion@ministerial.qld.gov.au
Web:              www.biotech.qld.gov.au
Beautiful weather, pristine beaches, relaxed lifestyle...combine these
with our internationally renowned scientists, world class
infrastructure, rich biodiversity and you have the perfect climate
for biotechnology businesses.
Company:            R5 Pharmaceuticals
Booth:             1679
Media Contact:         PAUL TITLEY
Phone:             44 115 912 4410
E-mail:            p.titley@r5pharma.com
Web:              www.r5pharma.com
R5 Pharmaceuticals is a contract service provider in drug development
for the pharma and biotech industries. Based on the BioCity campus,
Nottingham, R5 uses an efficient and integrated approach to
pharmaceutical development, from drug formulation and delivery
technology through to full scale manufacture. Led by a uniquely
experienced management team, R5 Pharmaceuticals provides solutions
for the development of safe and effective pharmaceutical materials to
be used in clinical studies. The facilities include one of the very
few cleanrooms in Europe, enabling the highest level of sterile
product development. R5 is also applying its expertise to rapidly
evolving areas such as paediatric products and nutraceuticals.
Company:            Randox Laboratories
Booth:             1881
Media Contact:         Glenn Morton
Phone:             44 (0) 28 9442 2413
E-mail:            marketing@randox.com
Web:              www.randox.com
Randox Laboratories Ltd is a privately owned diagnostic reagent and
equipment manufacturer and the leading British manufacturer of
clinical chemistry reagents. Randox has 25 years experience in
research, development, manufacture and marketing of high quality
diagnostic reagents and equipment for laboratory medicine. The Randox
portfolio includes Biochip Array Technology, clinical chemistry
automation systems, external quality assurance schemes, internet
driven QA systems, quality control materials, clinical reagents and
environmental diagnostics.
Company:            Raven biotechnologies, inc.
Media Contact:         Joseph Fisher
Phone:             650-624-2656
E-mail:            jmfisher@ravenbio.com
Web:              www.ravenbio.com
Raven biotechnologies, inc. is focused on the discovery of new drug
targets for life-threatening conditions and the development of
antibody products to treat them. Raven develops monoclonal antibody
therapeutics, discovery tools, and technologies using unique, tissue-
specific stem (i.e. progenitor) and tumor cells as antigens. Raven is
currently focused on developing MAb therapies for cancer. The
company's first clinical drug, RAV12, is a therapeutic antibody
against a novel target present on GI cancers (pancreatic, stomach,
and colon) as well as other adenocarcinomas. RAV12 is currently in a
US multicenter Phase I Clinical Trial and will begin Phase II trials
in mid-2007.
Company:            Regeron, Inc.
Booth:             2436 - Korea Pavilion
Media Contact:         Dahlkyun Oh, Ph.D.
Phone:             82-33-258-6262
E-mail:            dahlkyun@regeron.com
Web:              www.regeron.com
Regeron, Inc. - Strives for the healthy and productive long-life
through innovative medicine that improves and even reverses natural
and pathological manifestations of the old; Develops anti-aging
biotech products-especially proteins for cosmetic and pharmaceutical
industries. Currently on the market are hGH (human growth hormone)
products for cosmetic purposes. Its long term goal is to develop an
oral/pulmonary delivery system for protein drugs.
Company:            Renewable Energy Group, Inc.
Booth:             Iowa Pavilion Booth 1356
Media Contact:         Alicia Clancy
Phone:             712-667-3418
E-mail:            Alicia.clancy@regfuel.com
Web:              www.regfuel.com
Renewable Energy Group(R), Inc. is the biodiesel industry leader of
B100 sales and is the only full-service biodiesel company offering
plant management, risk management, raw material procurement, plant
construction, biodiesel production and biodiesel sales and marketing
services. By 2008, REG's network of commercial scale biodiesel plants
will have more than 200 million gallons of biodiesel available to the
growing marketplace.
Company:            Rentschler Biotechnologie GmbH
Booth:             1055/1057
Media Contact:         Friederike Braun
Phone:             0049 7392 701 555
E-mail:            biotech@rentschler.de
Web:              www.rentschler.de
Rentschler Biotechnologie is an independent, internationally operating
service company that has been established in the field of
biopharmaceuticals for over 30 years.
With an all-inclusive package of integrated services, we can support
you in all phases of product development. Our experienced staff
develops your product through an integrated, custom tailored offer of
biopharmaceutical services from the cell line to registration.
GxP certified services:
--Cell Line & Process Development
--Production of Active Pharmaceutical Ingredients
--Fill and Finish
--Analytics & Quality Control
--Regulatory Affairs & Quality Assurance
--Corporate Project Management
Company:            Restaino Bunbury & Associates Realtors
Booth:             Wisconsin Pavilion
Media Contact:         Bette McCarthy, CRP/GMS
Phone:             608-833-7777
E-mail:            mccarthy@restainobunbury.com
Web:              www.madisonrelocation.com
Full Service Relocation, Real Estate Firm. Delivering world class
services such as Home-finding, Rental Assistance. Community Tours,
Trailing Partner Program and much more!. Specializing in local and
global relocations. A silver member and the preferred vendor for the
Wisconsin Biotech and Medical Device Association.
Company:            Rondaxe Pharma L.L.C.
Booth:             New York Pavilion, Booth 1833
Media Contact:         Ann Kich
Phone:             315 469-2800 ext 202
E-mail:            akich@rondaxe.com
Web:              www.rondaxe.com
Rondaxe Pharma is a consulting firm that employs a diverse group of
senior level staff from the pharmaceutical industry with expertise in
chemical development, fermentation development, drug product
development, supply chain strategy, analytical development,
manufacturing operations, quality control, quality assurance, and
regulatory affairs. Using our systematic approach, combined with
depth and breadth of experience, Rondaxe's proactive strategies
position our customers for success. Rondaxe's staff supports our
clients with advice & council or will perform the work, providing
full implementation and execution capabilities. By working with
Rondaxe, our clients benefit by gaining one point of contact to the
broader multi-disciplined team.
Company:            SAGI
Booth:             1408
Media Contact:         Jacques-Henry VERGNE & Emmanuelle
                JOUANNET
Phone:             33 1 40 75 33 04
E-mail:            delehonte@sagi-immo.com
Web:              www.sagi-immo.com
Company:            San Francisco East Bay EDA
Booth:             1569
Media Contact:         Keith Sutton
Phone:             510 272-3885
E-mail:            keith@eastbayeda.org
Web:              www.eastbayeda.org
The East Bay - Bright Side of the San Francisco Bay:
--UC Berkeley, the nation's #1 public undergraduate institution &
graduate institution and 12 other colleges & universities
--Large R&D cluster anchored by three national laboratories with
combined budgets over $2 billion, and 13,000 employees
--Silicon Valley's growth area
--Over 35% of the Bay Area's land available for commercial development
--Almost 40% of the Bay Area's future housing potential
--The most robust & diversified economy in the Bay Area
--One of the nation's fastest growing airports
--The nation's 4th largest container seaport
Company:            Shanghai ChemPartner Co., Ltd.
Booth:             1633
Phone:             86-21-51320088
E-mail:            sales@chempartner.com
Web:              http://www.chempartner.cn
Founded in 2003, Shanghai ChemPartner Co., Ltd.("ChemPartner") is a
chemistry contract research company that provides customized services
to international pharmaceutical, biotech and chemical companies.
ChemPartner currently has a team of more than 400 chemists (by
December 31, 2006), including more than 50 PhDs, who either had
extensive R&D experiences with Pharmaceutical & Biotech companies and
universities abroad, or were trained at the top chemistry research
institutions in China.
Company:            SIP Bio & Nano Technology Development
                Co.,Ltd.
Booth:             China Pavilion 06
Phone:             13701417264
E-mail:            cheny@biobay.com.cn
Web:              www.biobay.com.cn
BioBay is the perfect location to start your career in the life-
science field. This 213 acre R&D park is conveniently located in the
China-Singapore Suzhou Industrial Park, Great Shanghai Area. We
provide excellent quality facilities and services, with a first-class
innovation environment, strong government support, a mature capital
security system, a seed fund & Biopharma incubator, and professional
public technical platforms and comprehensive service solutions. If
you are interested in BioBay or would like more information, BioBay
welcomes you to take a closer look.
Company:            Solano Economic Development Corporation
Booth:             #1569
Media Contact:         Earl Parker
Phone:             (208) 687-3075
E-mail:            earlijoe@wildblue.net
Web:              www.solanoedc.org
Originally founded in 1983 and known as SEDCORP, the Solano Economic
Development Corporation is a collaboration of private and public
investors that provides a confidential leadership role for economic
development marketing in Solano County and its seven cities: Benicia,
Dixon, Fairfield, Rio Vista, Suisun City, Vacaville and Vallejo.
The mission of the Solano Economic Development Corporation is to
attract, grow, and retain business and industry in Solano County that
enhance the economic vitality and quality of life in our communities.
Company:            Southern Research Institute
Booth:             1643 - Alabama Pavilion
Media Contact:         Rhonda Jung
Phone:             205-581-2317/Cell: 205-337-9634
E-mail:            Jung@sri.org
Web:              www.SouthernResearch.org
Southern Research is an independent not-for-profit center for
scientific and contract research, known for innovative leadership in
preclinical drug discovery and development, and environment and
energy research. Clients include the National Institutes for Health,
U.S. Departments of Defense and Energy; the EPA, NASA, and many major
private and public pharmaceutical and biotech companies. Southern
Research excels in preclinical studies of cancer, infectious diseases
and emerging public health threats, CNS, and research into
alternative energy sources. Scientists there have discovered six FDA-
approved cancer drugs, with six additional drugs in the clinic, and
evaluated almost 70% of all other FDA-approved cancer drugs on the
market.
Company:            Southside Bethlehem Keystone Innovation
                Zone
Booth:             Pennsylvania Pavilion
Media Contact:         Stephen Melnick
Phone:             (610) 266-7535
E-mail:            smelnick@lehighvalley.org
Web:              www.lehighvalley.org (KIZ icon)
The Southside Bethlehem KIZ cultivates entrepreneurial opportunities,
by aligning the resources of Lehigh University, and Northampton
Community College with the existing business community.
Our Technology Transfer Grant Program has provided over $250,000 in
assistance to startup and early stage companies,enabling them to
continue with their research and growth during critical times in
their development.
Our undergraduate internship program is designed to provide student
internships in three distinct areas of concentration. Existing
businesses, startup companies, agencies, and research centers. It is
the intent of the Zone to create an awareness of the employment
opportunities the "Life Sciences" may present within the KIZ.
Company:            Southwest Research Institute
Booth:             2520
Media Contact:         Joe McDonough
Phone:             210-522-4632
E-mail:            Joe.mcdonough@swri.org
Web:              www.swri.org
SwRI offers synthesis, formulation, and analytical contract research
services for all stages of the drug development process, from drug
concept idea to clinical trials. Custom synthesis and medicinal
chemistry services offer computational modeling capabilities,
synthetic route design and execution (including medium to large-scale
synthesis), and small-scale analog preparation. Contract services are
available for large-scale API synthesis, pre-formulation development,
spray drying and disk atomization. Other particle formation
capabilities for microencapsulation-based, controlled-release drug
delivery technologies for oral, injectable, implantable, nasal and
transdermal platforms include GLP analytical and bioanalytical
services, which include method development for pharmaceutical
evaluation. SwRI has dedicated cGMP and cGLP facilities for clinical
API and drug product preparation and evaluation.
Company:            Springboard Atlantic Inc.
Booth:             807
Media Contact:         Tanya Moxley
Phone:             902 421 5678
E-mail:            info@springboardatlantic.ca
Web:              www.springboardatlantic.ca
Springboard Atlantic is a network of fourteen Atlantic Canadian
universities with a mandate to increase the rate of commercialization
of university research and development. Springboard makes connections
to encourage the transfer of knowledge and technology to the private
sector and therefore bring research to life.
Springboard provides technology transfer resources to Atlantic
universities so they can share services that would only be available
at large institutions, providing equal opportunities to those big and
small.
Company:            SR Pharma plc / Atugen AG
Booth:             668
Ticker Symbol & Exchange:   SPA.L
Media Contact:         Thomas Christely
Phone:             0049 30 9489 2800
E-mail:            christely@atugen.com
Web:              www.srpharma.com / www.atugen.com
SR Pharma plc (new name: Silence-Therapeutics plc) is a European
biopharmaceutical company, listed on AIM. SR Pharma is focused on
RNAi therapeutics since mid 2005 when it acquired Atugen AG (Berlin)
a world leader in RNAi therapeutics, a Nobel Prize winning technology
that "silences" genes linked to the onset of disease. The Company has
developed novel, chemically modified proprietary siRNA molecules
("AtuRNAi") and a proprietary delivery system ("AtuPLEX"). The
Company has sublicensed one of its AtuRNAi compounds (RTP-801i) to
Pfizer through its collaboration partner Quark Biotech Inc. This
compound entered the clinic in early 2007.
Company:            Staubach Company, The
Booth:             1016
Media Contact:         Liz Brazil
Phone:             617-878-9200
E-mail:            Liz.brazil@staubach.com
Web:              www.staubach.com
The Staubach Company is a leading global real estate advisory firm
that delivers cost-effective solutions for the users of office,
industrial and retail space. We have extensive experience in
strategic consulting, site selection, acquisition, disposition,
construction consulting / project management, real estate
administration, portfolio management, financing and capital
solutions.
More than 1,400 people in 68 offices throughout North America
represent Staubach's 2,850 clients. Staubach completed 6,750
transactions totaling $26 billion and 835 million square feet during
the fiscal year ending June 2006.
Worldwide, the DTZ Staubach Tie Leung partnership has more than 11,800
professionals delivering solutions to multinational clients.
Company:            Sterne, Kessler, Goldstein & Fox
                P.L.L.C.
Booth:             2676
Media Contact:         Kathryn Holmes Johnson
Phone:             301-908-8116
E-mail:            kholmesj@skgf.com
Web:              www.skgf.com
Sterne Kessler Goldstein & Fox is an intellectual property (IP) law
firm based in Washington, DC with a national/international client
base. We have a biotechnology practice group focused on the specific
IP needs of innovators in the biotech space.
We are one of the premier IP firms in the world with expertise in the
area of biotechnology, having practiced in the field for over twenty
years. We prepare and prosecute patent applications before the U.S.
and foreign patent offices, conduct interferences, oppositions,
arbitrations, litigations (both as counsel and expert witnesses),
advise worldwide biotechnological clients on intellectual property
strategy, trade secrets, evaluation of patent portfolios,
acquisitions, and employment agreements.
Company:            Stricent AB
Booth:             2065
Media Contact:         Jerker Ringstrom
Phone:             46 46 38 90 00
E-mail:            info@stricent.com
Web:              www.stricent.com
Stricent provides products and services that support the drug
development process. Our goal is to help biotech and pharmaceutical
companies reduce the time, costs and risk of development.
Combining our knowledge in drug development and regulatory structures
with our proprietary digital process tools, we tailor solutions to
meet each client's specific needs, whether it is a small biotech
start-up or a large pharmaceutical entity. We know that a structured
process is equally important for both.
Company:            Suven Life Sciences Limited
Booth:             India Pavilion
Ticker Symbol & Exchange:   Suven, National Stock Exchange in India
Media Contact:         Mr. Venkatraman Sunder
Phone:             91 40 6666 8666
E-mail:            vsunder@act-india.com
Web:              www.act-india.com
ACT is a full spectrum Contract/Clinical Research Organization, part
of Suven Life Sciences, composed of highly experienced professionals.
Our meticulous planning process, expertise on different therapeutic
areas and our relationship with investigators provide service
offering with speed, efficiency and quality. Count on, be it
regulatory affairs, site management, project management or data
management with technology platform like Oracle Clinical will provide
rewarding experience to our customers. And added to Suven's
capabilities and new business model, Drug Discovery and Development
Support Services (DDDSS), we offer seamless transition through every
stage in drug development for global Pharma, Biotech and Medical
device companies.
Company:            Syntarga BV
Booth:             2633
Media Contact:         Dr. Vincent de Groot
Phone:             31 24 3652878
E-mail:            info@syntarga.com
Web:              www.syntarga.com
Syntarga B.V. is a biopharmaceutical company creating innovative
chemistries to link potent cell-killing payloads to tumor-specific
antibodies. The Company develops (combinations of) unique linker
technologies and novel highly potent toxins. Syntarga generates
ready-for-conjugation payloads yielding successful Antibody-Drug
Conjugates (ADCs).
Company:            Taiwan Liposome Company
Booth:             2517
Media Contact:         Ling-yao Lin
Phone:             886-2-26557377
E-mail:            info@tlcbio.com
Web:              www.tlcbio.com
TLC is a biopharmaceutical company engaging in research, development
and commercialization of proprietary drug delivery system for
improving the treatment of major diseases and conditions, such as
cancers, arterial diseases, ophthalmic conditions and fungal
infections. TLC has a team of researchers, management, production
experts, and advisers who are building TLC into an organization
recognized for its excellence in targeted delivery and rapid
advancement of products through the drug development process in South
San Francisco, California and Taipei, Taiwan. The Company was chosen
among Red Herring Asia Top 100 private companies in 2006.
Company:            Tandem Labs
Booth:             2707
Media Contact:         Jean Pineault
Phone:             (609) 228-0201
E-mail:            jean.pineault@tandemlabs.com
Web:              www.tandemlabs.com
Tandem Labs is a leading bioanalytical and immunoanalytical contract
research organization (CRO) supporting pharmaceutical and
biotechnology companies with their discovery, preclinical, and
clinical drug development programs. Our laboratory menu includes
advanced mass spectrometry, immunoanalytical support,
pharmacokinetics, and pharmacodynamics. We also provide clinical
research services through our strategic partners, Advanced Biomedical
Research, Inc. (ABR) and Qualia Clinical Services. By combining
scientific expertise, responsive communication, disciplined
compliance, flexible service, and a commitment to information
technology, Tandem Labs provides its clients with the data they need
to confidently decide how to advance their programs.
Company:            Translational Genomics Research
                Institute
Booth:             2255
Media Contact:         Galen P. Perry
Phone:             602.343.8423
E-mail:            gperry@tgen.org
Web:              www.tgen.org
The Translational Genomics Research Institute (TGen), a non-profit
501(c)(3) organization, with a focus on developing earlier diagnoses
and smarter treatments. Translational genomics research is a
relatively new field employing innovative advances arising from the
Human Genome Project and applying them to the development of
diagnostics, prognostics and therapies for cancer, neurological
disorders, diabetes and other complex diseases. TGen bases its
research on personalized medicine and the institute plans to
accomplish its goals through robust and disease-focused research.
Company:            TSX Group
Booth:             715
Ticker Symbol & Exchange:   X
Media Contact:         Steve Kee
Phone:             416-947-4682
E-mail:            Steve.kee@tsx.com
Web:              www.tsx.com
TSX Group operates Canada's two national stock exchanges, Toronto
Stock Exchange serving the senior equity market and TSX Venture
Exchange serving the public venture equity market, Natural Gas
Exchange (NGX), a leading North American exchange for the trading and
clearing of natural gas and electricity contracts and Shorcan Brokers
Limited, the country's first fixed income interdealer broker. TSX are
the initials attached to the core equity operations of TSX Group
(www.tsx.com): Toronto Stock Exchange, TSX Venture Exchange, TSX
Markets, TSX Datalinx, and TSX Technologies. TSX Group is
headquartered in Toronto and maintains offices in Montreal, Winnipeg,
Calgary and Vancouver.
Company:            UCB, Inc.
Media Contact:         Lisa Garman
Phone:             770-970-7500
E-mail:            Lisa.garman@ucb-group.com
Web:              www.ucb-group.com
UCB (www.ucb-group.com) is a leading global biopharmaceutical company
dedicated to the research, development and commercialization of
innovative pharmaceutical and biotechnology products in the fields of
central nervous system disorders, allergy/respiratory diseases,
immune and inflammatory disorders and oncology - UCB focuses on
securing a leading position in severe disease categories. Employing
over 8,500 people in over 40 countries, UCB achieved revenues of EUR
2.5 billion in 2006. UCB is listed on the Euronext Brussels Exchange
with a market capitalization of approximately EUR 6.0 billion.
Worldwide headquarters are located in Brussels, Belgium, and U.S.
headquarters are located in Atlanta, Georgia.
Company:            UK Trade & Investment
Booth:             1773
Media Contact:         Joseph Pickerill
Phone:             857-753-7887
E-mail:            joseph.pickerill@fco.gov.uk or
                joepickerill@mycingular.blackberry.net
Web:              www.uktradeinvest.gov.uk
UK Trade & Investment is the lead government organisation that helps
UK companies succeed in international markets and helps bring high
quality investment into the UK.
UK Trade & Investment welcomes the 60 plus UK companies and research
organisations who are attending BIO 2007.
This year at BIO, UK Trade & Investment will be unveiling a new drug
pipeline which includes cutting-edge research which shows just how
competitive UK's bio industry is.
Come to the UK Trade & Investment stand at BIO, find out why the UK is
number one for biotechnology in Europe. Or simply come and join our
Boston Tea Party and enjoy a cup of British Tea!
Company:            University of Nebraska Medical Center
Booth:             2523
Media Contact:         Vicky Cerino
Phone:             402 350-0898
E-mail:            vcerino@unmc.edu
Web:              www.unmc.edu
The University of Nebraska Medical Center will feature technologies,
including a revolutionary recombinant protein purification
technology. Allied Minds, a Boston-area pre-seed investment firm,
purchased the license for the technology from UNeMed, the
university's technology transfer company, formed Purtein LLC, and
made a $500,000 investment. UNMC researchers also are working on a
computer-aided orthopedic surgical system they hope will enable
surgeons to do faster, less invasive, more precise bone cutting and
alignment of knee implants. Biosecurity and biopreparedness
innovations will be featured, including the country's only 10-bed
patient biocontainment unit, laboratory data exchange, and
antimicrobial drug discovery.
Company:            United BioSource Corporation
Booth:             2849
Media Contact:         Tess Drahzal
Phone:             240 644 0420
E-mail:            info@unitedbiosource.com
Web:              www.unitedbiosource.com
UBC is a global pharmaceutical services organization that combines
deep scientific knowledge with broad execution expertise across the
lifecycle continuum.
Our focus is on generating real-world data to support the development
and commercialization of medical products for emerging and
established life science companies.
We partner with our clients to offer services in scientific research
and strategic consulting, late stage development, registries and drug
safety, data integration and analysis, clinical technologies,
investigator services, patient programs, medical education, and
market access services.
UBC specializes in offering innovative ways to study drugs and devices
with an emphasis on science, strategy, and execution.
Company:            Van Eperen Public Relations
Booth:             285
Media Contact:         Laura Van Eperen
Phone:             301.926.3394
E-mail:            laurav@vepublicrelations.com
Web:              www.vepublicrelations.com
Van Eperen Public Relations (VE PR) is a full-service public relations
and marketing firm serving clients around the globe. Located just
outside of Washington, DC, the VE PR team of communications
professionals works with domestic and international clients to help
each positively showcase its products, services and people. For more
information, go to www.vepublicrelations.com or call 1-301-926-3394.
Company:            Vetter Pharma-Fertigung GmbH & Co. KG
Booth:             961
Media Contact:         Suzan Frohmann
Phone:             0049-751-3700-0
E-mail:            info@vetter-pharma.com
Web:              www.vetter-pharma.com
Vetter is a worldwide specialist in the aseptic production of FDA-
approved pre-filled application systems. We support pharmaceutical
and biotech customers from development to launch of new products. Our
patented application systems give the customer a competitive edge in
global markets.
Company:            ViaLactia Biosciences (NZ) Limited
Booth:             1711 - New Zealand Pavilion
Media Contact:         Ashvin Sood
Phone:             64 21 685483
E-mail:            ashvin.sood@vialactia.com
Web:              www.vialactia.com
ViaLactia is a biotechnology company operating as a fully owned
subsidiary of Fonterra, the world's largest exporter of dairy
products. ViaLactia's goals are the identification, discovery and
commercialization of methods of selection of genes important to the
dairy industry i.e. those affecting pasture grass performance, milk
production & composition. ViaLactia's discoveries and technologies
have applications to the biofuel sector. We have identified novel
enzymes that facilitate the breakdown of plant cell walls into
simpler sugars amenable for conventional fermentation. These enzymes
are suitable for cellulosic ethanol production processes. They were
discovered via a metagenomic approach exploring the bovine rumen.
Company:            VioQuest Pharmaceuticals, Inc.
Booth:             1226
Ticker Symbol & Exchange:   VQPH.OB
Media Contact:         Brian Lenz
Phone:             908-766-4400
E-mail:            brian.lenz@vioquestpharm.com
Web:              www.vioquestpharm.com
VioQuest Pharmaceuticals focuses on acquiring, developing, and
commercializing targeted therapies with unique mechanisms of action
for oncology, viral and autoimmune disorders. VioQuest has two
targeted therapeutics in Phase I/IIa clinic trials: VQD-002 which
inhibits activation of Akt; and Lenocta(TM), an inhibitor of specific
protein tyrosine phosphatases. VioQuest and the U.S. Army are
planning to submit an NDA to the FDA in 2007 for Lenocta(TM) for the
treatment of leishmaniasis. VioQuest recently in-licensed Xyfid(TM) a
topical therapy for the treatment and prevention of Hand-Foot
Syndrome, which is expected to enter Phase II trials in the second
half of 2007.
Company:            Viragen, Inc.
Booth:             Room E on 5/9/07 at 10:00 a.m.
Ticker Symbol & Exchange:   VRA - Amex
Media Contact:         Douglas W. Calder
Phone:             954-233-8746
E-mail:            dcalder@viragen.com
Web:              http://www.Viragen.com
Viragen is a bio-pharmaceutical company engaged in the research,
development, manufacture and commercialization of therapeutic
proteins for the treatment of cancers and viral diseases. Our product
portfolio includes: Multiferon(R) (multi-subtype, human alpha
interferon) which is uniquely positioned in valuable niche
indications, such as high-risk malignant melanoma, and other select
cancers and infectious diseases; VG102, a novel monoclonal antibody
that binds selectively to an antigen that is significantly over-
expressed on nearly all malignant tumors; and VG106, a novel cytokine
targeting difficult-to-treat cancers. We are also pioneering the
development of The OVA(TM) System with the renowned Roslin Institute,
creators of "Dolly the Sheep", as a revolutionary manufacturing
platform for the large-scale, efficient and economical production of
human therapeutic proteins and antibodies, by expressing these
products in the egg whites of transgenic hens.
Company:            VWR
Booth:             533 (MBC Booth), 1300, 1301 (BIO
                Partners Pavilion Booth)
Phone:             610-431-1700
Web:              www.vwr.com
VWR is a leader in the global research laboratory industry and offers
more than 1,200,000 products, from more than 2,500 manufacturers, to
over 250,000 customers throughout North America and Europe. VWR's
primary customers work in the pharmaceutical, life science, chemical,
technology, food processing and consumer product industries.
Affiliates operate in 20 countries and employ approximately 6,100
people. Its mission is to deliver excellence in the distribution of
scientific supplies.
For more information, phone 1-800-932-5000, visit www.vwr.com, or
write, VWR International, Inc., 1310 Goshen Parkway, P.O. Box 2656,
West Chester, PA 19380-0906. (VWR and design are trademarks of VWR
International, Inc.)
Company:            Waban Software, Inc.
Booth:             2421
Media Contact:         Pratap Malik, Ph.D.
Phone:             617 899 8897
E-mail:            pmalik@wabansoftware.com
Web:              www.wabansoftware.com
Waban Software provides 21CFR11 and HIPAA complaint software products
and services for life-sciences information management.
Waban SMS, Waban LIMS and Waban Explorer are for biological sample
management, patient information management (de-identification &
anonymization), pharmacogenomics & pharmacogenetics lab information
management (LIMS) and for integration and analysis of biomarker,
genomics, image and clinical data.
Waban Explorer and Waban SCE are for managing the clinical trials
data, analysis and reports and the complex business processes
associated with the analysis and reporting process in a collaborative
21CFR11 compliant manner. Waban's products are integrated with all
major statistical analysis tools and clinical data management
systems.
Company:            Wesley Research Institute, The
Booth:             Queensland Clinical Trials Network
                (QCTN)
Media Contact:         Colleen McMillan
Phone:             61 7 3232 7264
E-mail:            research@wesley.com.au
Web:              www.wesleyresearch.org.au
The Wesley Research Institute is an independent, not-for-profit
organisation located in the grounds of The Wesley Hospital in
Brisbane, which is part of one of Australia's largest private
hospital groups.
The Institute conducts research that focuses on improving patient care
and quality of life. Our clinical and applied research aims to
discover, test and refine new techniques for better diagnosis and
treatment of illness and disease.
The Wesley Research Institute's Clinical Trials Centre is a purpose-
built and designed facility dedicated to conducting clinical trials
that has access to one the most comprehensive range of private
medical services in Australia.
Company:            Western Australian Institute for
                Medical Research
Booth:             1515
Media Contact:         Natalie Papadopoulos
Phone:             61 8 9388 9280
E-mail:            natalie@capturemedia.com.au
Web:              www.waimr.uwa.edu.au
The Western Australian Institute for Medical Research is a one-stop-
shop for your genomic, proteomic, microarray and antibody production
needs. WAIMR will soon provide additional translational services to
the global biotechnology and pharmaceutical industries with the
completion of a custom built, 24 bed, early phase (I/II) clinical
trial facility
Company:            Whitehead Institute for Biomedical
                Research
Booth:             C39
Media Contact:         Eric Bender
Phone:             617-258-9183
E-mail:            bender@wi.mit.edu
Web:              www.whitehead.mit.edu
Whitehead Institute is a biomedical research and education institution
with pioneering programs in stem cells, cancer, immunology,
regenerative biology, genetics and genomics. Wholly independent in
its governance and research, Whitehead shares a teaching affiliation
with Massachusetts Institute of Technology, where Whitehead's 15
faculty members hold joint appointments. At the leading edge of basic
scientific research, Whitehead has over 190 patents under license to
companies ranging in size from small local biotech firms to
multinational pharmaceutical companies.
Company:            Wilmer Cutler Pickering Hale and Dorr
                LLP
Booth:             Booth 552
Media Contact:         Lauren G. Coppola
Phone:             (617) 526-6998
E-mail:            lauren.coppola@wilmerhale.com
Web:              www.wilmerhale.com
WilmerHale is more than 1,100 lawyers strong, with offices in 11
cities across the globe. The firm offers unparalleled legal
representation across a comprehensive range of practice areas that
are critical to the success of our clients. We practice at the very
top of the legal profession and offer a cutting-edge blend of
capabilities that enables us to handle deals and cases of any size
and complexity. WilmerHale has represented life sciences clients in
boardrooms and courtrooms for four decades. As a result, we
understand the business of our life sciences clients and the
regulatory, competitive and consumer demands they confront.
Company:            Women In Bio
Booth:             2388
Media Contact:         Ms. Robbie Melton
Phone:             703-819-7647
E-mail:            womeninbio@comcast.net
Web:              www.womeninbio.org
Women In Bio (WIB) is a vibrant organization dedicated to the success
of women entrepreneurs, executives, scientists, students and
professionals in the biotech and life sciences industry. WIB plans
and presents unique and valuable educational programs that foster
professional and personal growth for women having careers in the life
sciences. Our innovative programs include:
--education programs and workshops
--networking events
--professional development seminars
--business opportunities for entrepreneurs and executives to meet
investors, attorneys, accountants, marketing executives and human
resource experts
--programs on science and entrepreneurship for young women in middle
and high school
Company:            Worcester Polytechnic Institute/Gateway
                Park
Booth:             533/C33
Media Contact:         Christopher Hardwick
Phone:             508-831-5874
E-mail:            hardwick@wpi.edu
Web:              www.wpi.edu
Gateway Park, is an 11 acre, mixed-use destination with five life
sciences buildings totaling 500,000 sq. ft. of adaptable lab space,
loft condominiums and several retail establishments. It is situated
in the 55-acre Gateway redevelopment district, comprised of numerous
businesses, offices, and restaurants, as well as a Courtyard by
Marriott hotel.
WPI, a national research university, offers degrees in science,
engineering, management, social sciences, and humanities. Its Life
Sciences and Bioengineering Center, the first building at Gateway
Park, opened in April 2007. The center serves as the focal point for
life sciences and biotechnology graduate education and research at
WPI.
Company:            WXYZ Group
Booth:             533/A18
Media Contact:         Margarita Hunter
Phone:             617-923-7600
E-mail:            margarita.hunter@wolfelabs.com
Web:              www.wxyzgroup.com
The WXYZ Group includes Wolfe Laboratories, Xtal BioStructures, Y-
Point BioAnalytical and Zenith BioVentures. These companies provide
specialized research and development services to the
biopharmaceutical industry, and partner with drug discovery
organizations to overcome challenges and accelerate the growth of
intellectual property.
--Wolfe Laboratories - analytical, preformulation and formulation
services.
--Xtal BioStructures - structural characterization and structure-based
drug design for drug targets and therapeutics using X-ray
crystallography.
--Y-Point BioAnalytical - LC/MS/MS-based bioanalytical and protein
characterization services.
--Zenith BioVentures - partners with discovery groups to provide early
stage drug development on proprietary investigational therapeutics to
address unmet needs in oncology and neurology.
Company:            Xcellerex, Inc.
Booth:             2381
Media Contact:         David Monson
Phone:             508-480-9235 x247
E-mail:            dmonson@xcellerex.com
Web:              www.xcellerex.com
Xcellerex, a technology integration company, offers disposable
technologies and top quality contract manufacturing services to the
biopharmaceutical industry. Our management team has unique experience
in drug development, taking biologics from preclinical development to
FDA approval.
Xcellerex has created a new paradigm for building manufacturing
systems in which process automation, fully disposable manufacturing
components and portable modules (FlexFactory(TM)) are integrated to
create alternatives to traditional stainless steel manufacturing
facilities.
Our 'Try and Take' model provides maximum flexibility and cost
effective manufacturing capabilities to our customers. We are
committed to our customer's success in 'speeding medicines to people'
by providing them excellent services and technology. Call or email us
for details.
Company:            XOMA, Ltd.
Booth:             2067
Ticker Symbol & Exchange:   XOMA
Media Contact:         David Boyle
Phone:             510-204-7234
E-mail:            boyled@xoma.com
Web:              www.xoma.com
XOMA is a leader in the discovery, development and manufacturing of
therapeutic monoclonal antibodies (mAbs). XOMA's mAb platform
includes leading commercial antibody display phage libraries,
hybridoma, Human Engineering(TM), affinity maturation technologies.
XOMA also has a fully integrated product development infrastructure,
including cell line and process development, preclinical and clinical
functions, and manufacturing. XOMA's pipeline includes both
proprietary products and collaborative programs. XOMA receives
royalties for RAPTIVA(R) and LUCENTIS(R). Other strategic
collaborations include Novartis International AG (formerly Chiron
Corporation), Schering-Plough Corporation, Takeda Pharmaceutical
Company Ltd. and Lexicon Genetics. XOMA has Human Engineering(TM)
agreements with AVEO Pharmaceuticals, Inc. and Attenuon, LLC.
Company:            ZENOAQ Nippon Zenyaku Kogyo Co., Ltd.
Booth:             2757 Japan Pavilion
Media Contact:         Mr. SAZE KOUICHI / Mr. Yan Zhen
Phone:             81-(0)24-945-2722
E-mail:            zhen-yan@zenoaq.jp
Web:              http://www.zenoaq.jp
ZENOAQ is a new name in cell storage reagent supply marketplace.
However a company with 61 years history of corporate life and animal
science based business behind it is anything but new. We have the
production system complied with GMP and the R&D system in accordance
with GLP standard. CELLBANKER is a brand name of cell freezing and
thawing products of ZENOAQ, CELLBANKERs have serum type, serum
replacement type and serum-free type. CELLBANKER do not need proguram
freezer, cells suspended in CELLBANKER can be directly frozen in a
deep freezer (-80 degree C).
Company:            Zoomedia, Inc.
Booth:             California Pavilion, Booth Number 1465
Media Contact:         Vanessa Silva, Director Client Services
Phone:             415.474.1192 x250
E-mail:            Vanessas@zoomedia.com
Web:              www.zoomedia.com
Founded in 1994, Zoomedia provides life science clients with a full
range of communications and marketing services, from analysis through
strategic planning, implementation, and production. We accelerate
client success through intelligent communication initiatives that
directly support business goals. By developing and implementing the
right communication program at the right time, Zoomedia ensures that
your company rises above the noise of what is an already crowded and
fast growing market.



Note to Editors: Business Wire's PressPass allows you to create free, custom Web, RSS, and email-based news feeds from more than 160 industry options, dozens of subject categories and thousands of geographic preferences as well as by specific company filters. In addition, PressPass subscribers have access to exclusive content, experts, company profiles, email alerts, survey services and other media services.

Note to Event Organizers: Add your trade show, conference, or event to http://www.tradeshownews.com, Business Wire's online event calendar. For information, email tradeshow@businesswire.com.

[ Back To SIP Trunking Home's Homepage ]

Loading
Subscribe here for your FREE
SIP TRUNKING enewslettter.

Featured Partner


Featured Whitepapers

SIP Security for the Enterprise
Voice over IP (VoIP) is incorporated into a variety of computer networks, both public and private, and used for everyday transactions and communications among carriers, businesses, government agencies...

Making A Broadband Purchase Decision
Businesses today have many options for broadband connectivity. Clarifying your particular business needs prior to selecting a broadband provider will ensure an optimal match of broadband service to your requirements.

Voice-Optimized Network Delivers Premier Call Experience
Customers equate call quality with business quality. Real-time communication, interpersonal interaction, and the cordial tone of a call center representative can create a positive impression of your business that no email can match.

Featured Case Studies

Business Telecom Expenses Reduced 50%
A small to medium sized company in the midwest was interested in migrating to IP Communications, but in today's economy, they were hesitant to upgrade their communication system due to their perception that the cost would outweigh the benefits.

Multi-State Company Cuts Telecom Costs 50%
A multi-site, multi-state company with extensive monthly long distance fees and toll-free charges did not have adequate broadband for Broadvox SIP Trunking requirements, nor did they have a SIP enabled telephone system.

Discover Leisure Connects Remote Users to its IP-PBX
Discover Leisure is one of the largest resellers of caravans and motor homes in the UK. With 15 branch of?ces all over the country, the company spent a great deal of money every month just on internal phone calls.

Featured eBOOKS

Internet+: The Way Toward Global Unified Communication
Connecting the telephony of the enterprise PBX or Unified Communications (UC) system using SIP trunks instead of conventional telephone lines has been very successful in recent years.

What is SIP Trunking? Edition 2
SIP trunking is becoming more of a focus for service providers. One key issue many service providers face when deploying SIP trunks is NAT, or Network Address Translation, traversal.

What is SIP Trunking? Edition 1
A vast resource for information about all things SIP - including SIP, security, VoIP, SIP trunking and Unified Communications.

Featured Videos

Broadvox VAR Testimonial VAR 1:
Part 1 of the VAR (Value Added Reseller) Partner Program Testimonials for Broadvox...

E-SBCs AS The Demarcation Point:
Ingate's Steve Johnson talks to Erik Linask about the role session border controller plays as the demarcation point at...

Demystifying DPI
How can deep packet inspection protect your SIP traffic as well as your entire network?

Featured Resources

Partner Program Overview:
Over 4,000 VARs, Master Agents, Solution Providers, and Independent IT Professionals trust Broadvox. We offer customized services and solutions to fit seamlessly into any company's business model. And when you partner with Broadvox, every member of our team stands behind you and your customers 100%...

SIP Trunk UC Summit

What's New

Presenting the New Ingate/Intertex Website:
Internet+ is an extended Internet access allowing high quality SIP (Session Initiation Protocol) based real-time person-to-person communication, everywhere and for any application. It applies to both fixed and mobile networks ...

Featured Blogs

Featured Webinars

Secure SIP Trunking:
What You Need to Know

Successfully Deploying Enterprise SIP Trunking:
Tools and Techniques for Overcoming Common Roadblocks

Featured Podcasts

Getting the Most Out of Your SIP Trunks:
Ingate's Steve Johnson and TMC's Erik Linask discuss how best practices forgetting the most out of SIP Trunking services and common pitfalls to avoid.

Featured Datasheets

Ingate SIParator E-SBCs
Adopting SIP is a simple process with the Ingate SIParator, the secure enterprise session border controller (E-SBC). The SIParator makes secure SIP communications - including VoIP,SIP trunking and more - possible while working seamlessly with your existing network firewall.

Ingate Firewalls
Everyone is talking about enterprise usage of VoIP, instant messaging and other types of realtime communications including presence and conferencing.

SIP Trunk Solutions for Service Providers
The award-winning Ingate Firewall and Ingate SIParator deliver a high quality, reliable SIP trunk connection between the customer's IP-PBX and the service provider network, and solve interoperability issues to simplify deployments and support for remote diagnosis of reported issues.